Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
No fee travel rewards cards come with various features. Learn what to anticipate when using them for your travels.
14,246 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Investors eyeing $20,000 a month in dividend income must balance capital, yield, and risk as market conditions shift ...
An insider stake moved when a Freshworks executive sold over 32,577 shares for roughly $275,000. This article breaks ...
Visa is exploring an internal stablecoin platform that would give its enterprise clients access to Origin Protocol's ...
A casual encounter spirals into a viral video and a hard look at how privacy gaps can drain your wallet. This piece t...
A strong quarter from TSMC is more than a one-off beat. This analysis explains why tsmc's revenue grew last and how c...
Oracle posted stronger-than-expected cloud results for Q3 FY2026, sending ORCL higher and helping the stock lead tech...
When big-name releases head to vinyl, your wallet feels the impact. This guide breaks down budgeting, costs, and prac...
Investors often wonder where will Realty Income head in ten years. This article breaks down how its net-lease model, ...
ASML dominated the latest quarter with strong results and higher guidance. This article breaks down what that could m...
As tensions rise, Iran warns of $200 barrels even as the U.S. and IEA launch a massive emergency oil release. The mov...
Sandisk surged more than 3,000% in the past year, turning heads and raising questions about valuation and future move...